Although the in vivo state of Tay-Sachs mice does not truly recapitulate the in vivo scenario of TSD patients, and not much is known about the status of PPARα in TSD, our results suggest that oral GFB may have therapeutic importance in TSD. This evidence concerns the gene PPARA and Tay-Sachs disease.